2nd Quarter - Report

BROWN RUDNICK LLP for APOTEX CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 3610, Food and Drug Import Safety Act

Foreign entity interest: Apotex Holdings Inc, the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.

LobbyistCovered position, as disclosed
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3610 (110th)

Medicare/Medicaid MMM

S. 1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 6331 & S. 3101,Medicare Improvements for Patients and Providers Act of 2008

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interest in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.

LobbyistCovered position, as disclosed
HENRY W MENN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1951 (110th), S. 3101 (110th), H.R. 6331 (110th), H.R. 3700 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.